Anticoagulation, traditionally with unfractionated heparin (UFH), is a cornerstone of therapy for patients with<unk>  angina]]/[[NSTEMI. 
Some of the agents available in this category include unfractionated heparin, low molecular weight heparin, direct thrombin inhibitors (e.g., bivalirudin) factor Xa Inhibitors (e.g., fondaparinux),  and warfarin. These agents are also sometimes referred to as antithrombins, although, it should be noted that they often inhibit one or more proteins in the coagulation cascade before thrombin.
Unstable angina / non ST elevation myocardial infarction anticoagulant therapy
ST elevation myocardial infarction anticoagulant and antithrombotic therapy
Unstable angina / non ST elevation myocardial infarction factor Xa inhibitors therapy
ST elevation myocardial infarction fibrinolytic therapy
ST elevation myocardial infarction aspirin therapy
Unstable angina / non ST elevation myocardial infarction direct thrombin inhibitors therapy
Unstable angina / non ST elevation myocardial infarction unfractionated heparin therapy
Unstable angina / non ST elevation myocardial infarction low molecular weight heparin therapy